Safety and Efficacy of Ranibizumab in Diabetic Macular Edema

NCT01131585 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

128

Enrollment

INDUSTRY

Sponsor class

Stopped European drug approval.

Conditions

Visual Impairment Due to Diabetic Macular Edema

Interventions

PROCEDURE: Active laser photocoagulation
DRUG: Sham injections
DRUG: Ranibizumab 0.5 mg

Sponsor

Novartis Pharmaceuticals